1 3 Background: Peripheral monocyte count is an assessable parameter. Recently, evidence 1 4 However, no significance was detected for preoperative monocyte in multivariate analysis. 3 1 Conclusions: Elevated early postoperative peripheral monocyte count was an independent 3 2 prognostic factor of poor prognosis and inferior clinicopathological features for patients with 3 3 operable lung adenocarcinoma or squamous cell carcinoma by lobectomy. 3 4
Introduction 5 7
Lung cancer was the leading cause of cancer-related death worldwide, with 5-year survival rates 5 8 of less than 17% [1] . Among all types, non-small-cell lung cancer (NSCLC) accounts for 5 9 6 blood routine examination, Chest and brain and upper abdomen CT scan at each follow-up. Bone 1 1 5 scintigraphy was performed every 12 months. Particularly, all the patients treated in our 1 1 6 department received phone call following-up regularly, during which we recorded their living 1 1 7 status, tumor recurrence/metastasis condition, and sequential treatments such as chemotherapy 1 1 8 and/or radiotherapy, etc. The patients were followed until August 31, 2017 or until they died. 1 1 9
Statistical analysis 1 2 0
Receiver operating characteristic (ROC) curve was performed to search the best cut-off value for 1 2 1 monocyte count to stratify patients at a high risk of tumor recurrence, distant metastasis, or death. 1 2 2
In the ROC curve, the point with the maximum sensitivity and specificity was selected as the best 1 2 3 By analyzing the ROC curve, the cut-off value for preoperative monocyte count was 0.375*10 9 /L 1 5 0 with the area under the curve (AUC) of 0.566; while for postoperative monocyte count, the cut-off 1 5 1 value was 0.845*10 9 /L with AUC of 0.692 ( Figure 2 ). The baseline characteristics were stratified 1 5 2 by high versus low preoperative monocyte and early postoperative monocyte count ( Table 1 ). The 1 5 3
preoperative monocyte was detected to be associated with male gender (P<0.001), smoking 1 5 4 history (P<0.001), T stage (P=0.014) and histological type (P<0.001). For early postoperative 1 5 5
group, compared to the low monocyte count group, male gender (P<0.001), positive smoking 1 5 6 history (P=0.005), and higher N stage (P=0.002) and higher tumor stage (P=0.026) were more 1 5 7 common found in high monocyte count group. The association between preoperative or 1 5 8 postoperative monocyte and clinical characteristics were presented in Table 1 in details. 1 5 9
We further performed Kaplan-Meier method to identify difference of survival rates between two 1 6 0 groups stratified by monocyte count (low vs. high) of both preoperative and early postoperative 1 6 1 group. For preoperative group, the 1-year OS of low and high subgroups were 95% and 93% 1 6 2 (P=0.003), and the 1-year DFS of low and high subgroups were 82% and 85% (P=0.106). The 1 6 3
3-year OS of low and high subgroups were 82% and 74% (P=0.003), and the 3-year DFS of low 1 6 4 and high subgroups were 67% and 60% (P=0.106), respectively. Additionally, the 5-year OS of 1 6 5 low and high subgroups were 72% and 58% (P=0.003), and the 5-year DFS of low and high 1 6 6 subgroups were 62% and 51% (P=0.106). As for the early postoperative group, the 1-year OS of 1 6 7 low and high subgroups were 96% and 90% (P=0.004), and the 1-year DFS of low and high 1 6 8 subgroups were 90% and 71% (P<0.001). The 3-year OS of low and high subgroups were 89% 1 6 9
and 62% (P<0.001), and the 3-year DFS of low subgroup was 78% compared to 41% in high 1 7 0 group (P<0.001). In addition, the 5-year OS of low and high subgroups were 79% and 46% 1 7 1 (P<0.001), and the 5-year DFS of low and high subgroups were 72% and 33% (P<0.001). Overall, 1 7 2 an early postoperative elevated monocyte count was significantly associated with poor OS 1 7 3 (P<0.001) and DFS (P<0.001) ( Figure 3 ). In further analysis, high level postoperative monocyte 1 7 4 count was associated with poor OS and DFS in both adenocarcinoma and squamous carcinoma 1 7 5 subgroups ( Figure 4 ). These differences were also significant in subgroup analysis when stratified 1 7 6 by gender, age, smoking history, stage, T stage, N stage and surgical procedure in postoperative 1 7 7 group ( Figure 5 , Figure 6 ). On the contrary, no statistical significance was seen in subgroup 1 7 8 analysis of preoperative group. 1 7 9
Univariate prognostic analysis was performed to detect the prognostic significance of 1 8 0 clinicopathological factors, and preoperative and early postoperative blood monocyte count ( Table  1 8 1 2). N stage (P<0.001), tumor stage (P<0.001), histological type (P=0.014), preoperative (P=0.023) 1 8 2 and postoperative monocyte count level (P<0.001) were significantly associated with DFS, while 1 8 3 age (P=0.017), surgery procedure (P=0.002), T stage (P=0.003), N stage (P<0.001), tumor stage 1 8 4 (P<0.001), preoperative(P=0.024) and postoperative monocyte count level (P<0.001) showed 1 8 5 significant relationships with OS. The clinicopathological factors proved to be prognostic 1 8 6 predictors in univariate analysis were included as covariates in further multivariate analysis ( Table  1 8 7 3). Finally, thoracotomy (HR=1.520, 95%CI: 1.117-2.069, P=0.008), positive N status (HR=2.506, 1 8 8 The mechanisms of elevated monocyte count related with poor prognosis of several kinds of 2 2 5 tumors were still not clearly elucidated. There were several possible explanations. First, it was 2 2 6
hypothesized that monocytes are attracted by several cytokines or chemokines to the tumor site 2 2 7
and then differentiated into tumor-associated macrophages (TAMs), which further promoted those 2 2 8
invading leukocytes to bring out potentials of angiogenesis, motility, and invasion [25, 26] . might suggest a complex association between peripheral TAMs (M2 type) and monocytes, which 2 5 0 still called further studies to verify. Moreover, the reason why we focused on the early 2 5 1 postoperative period--the most turbulent stage of host immune system caused by surgical trauma 2 5 2 and/or tumor removal effect probably was that we hypothesized that change in this period of 2 5 3 immune environment might relate with tumor progression more closely than that of the 2 5 4 preoperative data. 2 5 5
In the present study, an elevated early postoperative monocyte count was shown to predict a poor 2 5 6 DFS and OS both in the univariate and multivariate analysis. In addition, as shown in the 2 5 7 subgroup analysis, the monocyte count was found to be significantly associated with poor 2 5 8 prognosis when stratified by gender, age, smoking history, TNM stage, surgical procedure and 
